Additionally, glycogen synthase kinase 3β (GSK3β) and CC chemokine receptor 6 (CCR6) have been identified as upstream positive regulators of TAFRO syndrome, which could serve as both diagnostic markers and therapeutic targets for TAFRO syndrome (20). Here, GSK3B is linked to Castleman-Kojima disease.